Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2173633Generated: October 30, 2026

5-(chloromethyl)-1-cyclopropyl-1H-1,2,3,4-tetrazole → 5-tert-Butyl-3-(1-cyclopropyl-1H-tetrazol-5-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

https://huagongshe.com/reaction/2173633

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(chloromethyl)-1-cyclopropyl-1H-1,2,3,4-tetrazoleHCID 25524499—
Reactant5-tert-Butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 71558205—
ReactantHCID 178441781HCID 178441781—
Product5-tert-Butyl-3-(1-cyclopropyl-1H-tetrazol-5-ylmethyl)-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidineHCID 86683360—

Reaction Steps

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-Butyl-7-(2-oxa-6-aza-spiro[3.3]hept-6-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 5-(chloromethyl)-1-cyclopropyl-1H-tetrazole and isolated as white solid. MS(m/e): 397.3 (MH+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09056866B2
Source datasetuspto-grants-2015_06
ORD IDord-5753ec2011ed4f79ab6b2aa87e2b4bbb
Source noteuspto-grants-2015_06